Blog Archives

US Morning Report: PMI at the lower end of the consensus range, really we need the Economic data?

The House price Index starts the boot on the housing recovery that has lasted a minor 20% uptick at the bottom of the cycle(Its a much repeated chart and there is another 50% in most urban indices to catch up

Tagged with: , , , , , , ,
Posted in Amitonomics, China, Emerging Markets, Healthcare, Investments, Retail Lifestyle, US

Global Mid-Day Report: Street catches Buzz, Crude and Gold hit the plate

Hardly a home run but a 6% jump set a few shorts on fire too in Crude as the easing of EU’s stalemate on ne funding still means a lot of uncertainty on the way easing will reach markets and

Tagged with: , , , , , , , , , , ,
Posted in Amitonomics, Europe, Financial Markets, Global, Healthcare, housing, Obamanomics, Retail Lifestyle, US

Global Mid Day Report: Natural Gas Inventories scare investors, Hospitals provide the only cheer

The Euro tumbled closer to breaking down below 1.24 levels today afternoon as the Natural Gas Report in the US shored up inventories of 3000 BCF by another 57 BCF of NatGas in US alone. Additions of record level inventories

Tagged with: , , , , , , ,
Posted in Amitonomics, Healthcare, Healthcare, Obamanomics, US

The hurrah for Healthcare – will it last! | Deal insight

Obamacare’s promise to provide Healthcare to all is in jeopardy though many states are in various stages of implementing it through public providers o f Medicare plans like Wellpoint. The order has been challenged in court and the court seemingly

Posted in Amitonomics, Healthcare, Obamanomics, US

Will you reelect this man?

Related Reading: The Ultimate Obama Survival Guide: How to Survive, Thrive, and Prosper During Obamageddon 2012 International Building Code American Grown: The Story of the White House Kitchen Garden and Gardens Across America 2012 International Residential Code for One- and

Tagged with: ,
Posted in Amitonomics, Bailout Nation, Healthcare, Obamanomics, TARP, US

Bristol Myers offers $2.5 bln for Inhibitex | Advantage Dealbook

This next Pharma deal happened in the first week of January 2012 itself as another maker of Hepatitis C drugs in Georgia recommended Bristol Myers’ $26 per share offer to its shareh olders. Shareholders will make a 160% gain over

Tagged with: , , , , , , , , ,
Posted in Amitonomics, Financial Markets, Healthcare, Healthcare, US

This week’s investment banking buzz and inspiration | Advantage Dealbook

Those coming back after the Christmas weekend have much to look forward to this week as equities in China, India and Brazil have started attracting investments, Europe almost a sideshow unlikely to come back but unlikely to take anyone else

Tagged with: , , , , , , ,
Posted in Dealbook, Healthcare, US

After Pfizer and Merck, J&J gets up to go | Advantage Dealbook

J&J has seen better days especially with brand rebuilding taking up the better part of 2010 and Pfizer and Glaxo running away with the honors with a Genzyme bid and the GAVI alliance prizes in $ 40 bln in vaccination

Tagged with: , , , , , , ,
Posted in Dealbook, Financial Markets, Healthcare, Healthcare, Mergers etc, US